BioLineRx provides the strategic development planning and execution needed to prepare promising compounds for introduction into the global arena. BioLineRx screens and selects compounds that have the greatest potential to produce safe, effective, approved, and marketed drugs. Through our proprietary selection process, BioLineRx evaluates a compound's potential for success by looking at its technological novelty, patent status, market need and approvability.

BioLineRx's drug development approach has a clear focus on identifying and following the critical pathway to commercialization. From feasibility testing, into preclinical work and through clinical trials, we maintain one focus, shortest time to FDA approval and commercial success, with experiments, models, materials, patent filings and end products that meet accepted US and international standards. Our drug development plans, include the steps necessary to achieve desired milestones, and we maintain rigorous scientific discipline and comprehensiveness in our development.

The BioLineRx drug development organization is specifically designed to support this approach with our medical team of specialist project managers supported by a core team of functional experts. The BioLineRx team leads the implementation of the drug development plan and meticulously chooses and manages certified and accredited subcontractors (e.g., GLP, GMP, GCP guidelines) according to the specific requirements of the compound and the indication under development, through the pre-clinical and clinical phases of development.